National Research Corporation $NRC Stake Increased by American Century Companies Inc.

American Century Companies Inc. grew its holdings in National Research Corporation (NASDAQ:NRCFree Report) by 7.3% in the first quarter, Holdings Channel.com reports. The firm owned 42,102 shares of the company’s stock after purchasing an additional 2,848 shares during the period. American Century Companies Inc.’s holdings in National Research were worth $539,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of NRC. Tower Research Capital LLC TRC lifted its stake in National Research by 376.6% in the 4th quarter. Tower Research Capital LLC TRC now owns 2,507 shares of the company’s stock worth $44,000 after acquiring an additional 1,981 shares in the last quarter. Significant Wealth Partners LLC acquired a new stake in National Research during the 1st quarter worth about $131,000. M&T Bank Corp acquired a new stake in National Research during the 1st quarter worth about $164,000. Jane Street Group LLC boosted its position in National Research by 8.6% during the 4th quarter. Jane Street Group LLC now owns 10,605 shares of the company’s stock worth $187,000 after acquiring an additional 840 shares during the period. Finally, GAMMA Investing LLC lifted its position in shares of National Research by 45,978.8% in the first quarter. GAMMA Investing LLC now owns 15,206 shares of the company’s stock worth $195,000 after purchasing an additional 15,173 shares in the last quarter. Hedge funds and other institutional investors own 47.26% of the company’s stock.

National Research Price Performance

NASDAQ NRC opened at $15.40 on Friday. The company has a 50 day simple moving average of $15.05 and a 200-day simple moving average of $14.26. The company has a debt-to-equity ratio of 3.61, a current ratio of 0.70 and a quick ratio of 0.70. The firm has a market capitalization of $355.12 million, a price-to-earnings ratio of 20.26 and a beta of 0.47. National Research Corporation has a 52-week low of $9.76 and a 52-week high of $22.99.

National Research (NASDAQ:NRCGet Free Report) last posted its quarterly earnings results on Monday, July 28th. The company reported $0.28 earnings per share (EPS) for the quarter. National Research had a net margin of 12.78% and a return on equity of 83.52%. The business had revenue of $34.04 million during the quarter.

National Research Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, October 10th. Shareholders of record on Friday, September 26th will be given a $0.12 dividend. The ex-dividend date is Friday, September 26th. This represents a $0.48 dividend on an annualized basis and a yield of 3.1%. National Research’s dividend payout ratio is presently 63.16%.

About National Research

(Free Report)

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.

Further Reading

Want to see what other hedge funds are holding NRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Research Corporation (NASDAQ:NRCFree Report).

Institutional Ownership by Quarter for National Research (NASDAQ:NRC)

Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.